Patent · US Expired

Therapeutic targets in cancer

US7816076B2 · kind B2 · utility

0Cited by
66References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 24, 2005
Grant dateOct 19, 2010
Priority date
Expiry dateMay 24, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to novel sequences for use in detection, diagnosis and treatment of cancers, especially lymphomas. The invention provides cancer-associated (CA) polynucleotide sequences whose expression is associated with cancer. The present invention provides CA polypeptides associated with cancer that are present on the cell surface and present novel therapeutic targets against cancer. The present invention further provides diagnostic compositions and methods for the detection of cancer. The present invention provides monoclonal and polyclonal antibodies specific for the CA polypeptides. The present invention also provides diagnostic tools and therapeutic compositions and methods for screening, prevention and treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.